{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:09:46Z","timestamp":1790082586431,"version":"4.0.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.rpth.2025.103208","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:56:42Z","timestamp":1759798602000},"page":"103208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Thrombotic complications of glucocorticoids and anabolic steroids"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0808-8779","authenticated-orcid":false,"given":"Gerard","family":"Gurumurthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jecko","family":"Thachil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.103208_bib1","article-title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study","volume":"357","author":"Waljee","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2025.103208_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.annepidem.2014.01.009","article-title":"The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis","volume":"24","author":"Sagoe","year":"2014","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.rpth.2025.103208_bib3","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/bjh.17388","article-title":"Glucocorticoid use and risk of first and recurrent venous thromboembolism: self-controlled case-series and cohort study","volume":"193","author":"Orsi","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103208_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.rpth.2025.103208_bib5","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s11102-022-01261-9","article-title":"Hypercoagulability in Cushing\u2019s syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols","volume":"25","author":"Feelders","year":"2022","journal-title":"Pituitary"},{"key":"10.1016\/j.rpth.2025.103208_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102215","article-title":"Coagulation profiles during and after anabolic androgenic steroid use: data from the HAARLEM study","volume":"7","author":"Camilleri","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103208_bib7","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.124.071117","article-title":"Cardiovascular disease in anabolic androgenic steroid users","volume":"151","author":"Windfeld-Mathiasen","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.103208_bib8","article-title":"Is pulmonary embolism a chronic disease?","volume":"25","author":"Gurumurthy","year":"2025","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.rpth.2025.103208_bib9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study","volume":"173","author":"Johannesdottir","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.rpth.2025.103208_bib10","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/jth.14283","article-title":"Preadmission use of glucocorticoids and risk of cardiovascular events in patients with ischemic stroke","volume":"16","author":"Sundb\u00f8ll","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103208_bib11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case\u2013control study","volume":"90","author":"Souverein","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.rpth.2025.103208_bib12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/art.22418","article-title":"Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study","volume":"56","author":"Davis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rpth.2025.103208_bib13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.atherosclerosis.2006.05.019","article-title":"Use of oral corticosteroids and the risk of acute myocardial infarction","volume":"192","author":"Varas-Lorenzo","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.rpth.2025.103208_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/07853890.2016.1252055","article-title":"Markers of atherosclerosis in patients with Cushing\u2019s syndrome: a meta-analysis of literature studies","volume":"49","author":"Lupoli","year":"2017","journal-title":"Ann Med"},{"key":"10.1016\/j.rpth.2025.103208_bib15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000318566","article-title":"Cardiovascular disease in Cushing\u2019s syndrome: heart versus vasculature","volume":"92","author":"De Leo","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.rpth.2025.103208_bib16","first-page":"120","article-title":"Anabolic androgenic steroid abuse and cerebral venous thrombosis\u2014a case report","volume":"16","author":"Saraiva","year":"2020","journal-title":"US Neurol"},{"key":"10.1016\/j.rpth.2025.103208_bib17","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1055\/s-0031-1297371","article-title":"Doping and thrombosis in sports","volume":"37","author":"Lippi","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2025.103208_bib18","first-page":"1069","article-title":"Ingestion of androgenic-anabolic steroids induces mild thyroidal impairment in male body builders","volume":"76","author":"Deyssig","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rpth.2025.103208_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.drugalcdep.2015.04.013","article-title":"Anabolic steroids and cardiovascular risk: a national population-based cohort study","volume":"152","author":"Thiblin","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.rpth.2025.103208_bib20","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.116.026945","article-title":"Cardiovascular toxicity of illicit anabolic-androgenic steroid use","volume":"135","author":"Baggish","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.103208_bib21","article-title":"Testosterone treatment and risk of venous thromboembolism: population based case-control study","volume":"355","author":"Martinez","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2025.103208_bib22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/cen.12094","article-title":"Hypercoagulability in Cushing\u2019s syndrome: prevalence, pathogenesis and treatment","volume":"78","author":"Van Der Pas","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.rpth.2025.103208_bib23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fendo.2018.00805","article-title":"Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing\u2019s syndrome: a systematic meta-analysis","volume":"9","author":"Wagner","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.rpth.2025.103208_bib24","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1016\/j.jtha.2023.06.012","article-title":"Glucocorticoids regulate thrombopoiesis by remodeling the megakaryocyte transcriptome","volume":"21","author":"Grodzielski","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103208_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.phrs.2018.03.014","article-title":"Glucocorticoids impair platelet thromboxane biosynthesis in community-acquired pneumonia","volume":"131","author":"Cangemi","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.rpth.2025.103208_bib26","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3390\/ani13081299","article-title":"Role of prednisolone in platelet activation by inhibiting TxA2 generation through the regulation of cPLA2 phosphorylation","volume":"13","author":"Kim","year":"2023","journal-title":"Animals (Basel)"},{"key":"10.1016\/j.rpth.2025.103208_bib27","series-title":"Secondary thrombocytosis","author":"Rokkam","year":"2024"},{"key":"10.1016\/j.rpth.2025.103208_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/HJH.0000000000000415","article-title":"The hypertension of Cushing\u2019s syndrome: controversies in the pathophysiology and focus on cardiovascular complications","volume":"33","author":"Isidori","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.rpth.2025.103208_bib29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cvr\/cvn231","article-title":"Glucocorticoid response elements and 11\u03b2-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression","volume":"81","author":"Liu","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.rpth.2025.103208_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/frhem.2025.1540152","article-title":"The role of glucocorticoids in erythropoiesis","volume":"4","author":"Hanssen","year":"2025","journal-title":"Front Hematol"},{"key":"10.1016\/j.rpth.2025.103208_bib31","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.12998\/wjcc.v10.i21.7187","article-title":"Effects of glucocorticoids on leukocytes: Genomic and non-genomic mechanisms","volume":"10","author":"Jia","year":"2022","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.rpth.2025.103208_bib32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1055\/s-0040-1709475","article-title":"The central role of acute phase proteins in rheumatoid arthritis: involvement in disease autoimmunity, inflammatory responses, and the heightened risk of cardiovascular disease","volume":"46","author":"Bezuidenhout","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2025.103208_bib33","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.3748\/wjg.v11.i48.7639","article-title":"Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation","volume":"11","author":"Zezos","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rpth.2025.103208_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676756","article-title":"Von willebrand factor, factor VIII, and other acute phase reactants as biomarkers of inflammation and endothelial dysfunction in chronic graft-versus-host disease","volume":"12","author":"Lelas","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2025.103208_bib35","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/BF03345745","article-title":"Androgens and erythropoiesis: Past and present","volume":"32","author":"Shahani","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.rpth.2025.103208_bib36","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","article-title":"Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials","volume":"60","author":"Calof","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.rpth.2025.103208_bib37","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/gerona\/glt154","article-title":"Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin\/hemoglobin set point","volume":"69","author":"Bachman","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.rpth.2025.103208_bib38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-2003-44552","article-title":"Hyperviscosity in polycythemia vera and other red cell abnormalities","volume":"29","author":"Kwaan","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2025.103208_bib39","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1161\/01.CIR.91.11.2742","article-title":"Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses","volume":"91","author":"Ajayi","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.103208_bib40","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/ijlh.12188","article-title":"The sex specific effects of extraneous testosterone on ADP induced platelet aggregation in platelet-rich plasma from male and female subjects","volume":"36","author":"Banerjee","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.rpth.2025.103208_bib41","first-page":"647","article-title":"Procoagulant state in current and former anabolic androgenic steroid abusers","volume":"118","author":"Chang","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103208_bib42","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJM198306093082305","article-title":"Danazol Increases factor VIII and factor IX in classic hemophilia and Christmas disease","volume":"308","author":"Gralnick","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103208_bib43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0002-8703(93)90014-Z","article-title":"Coagulation abnormalities associated with the use of anabolic steroids","volume":"125","author":"Ansell","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.rpth.2025.103208_bib44","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0038-1661320","article-title":"Effect of stanozolol on factors VIII and IX and serum aminotransferases in haemophilia","volume":"53","author":"Greer","year":"1985","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103208_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-0040-1714398","article-title":"Anabolic\u2013androgenic steroid abuse impairs fibrin clot lysis","volume":"47","author":"Sidelmann","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2025.103208_bib46","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1097\/CM9.0000000000000407","article-title":"Anabolic-androgenic steroids and cardiovascular risk","volume":"132","author":"Liu","year":"2019","journal-title":"Chin Med J"},{"key":"10.1016\/j.rpth.2025.103208_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117238","article-title":"Anabolic-androgen steroids: a possible independent risk factor to cardiovascular, kidney and metabolic syndrome","volume":"495","author":"De Melo Junior","year":"2025","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.rpth.2025.103208_bib48","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jacc.2019.10.058","article-title":"Incident heart failure and long-term risk for venous thromboembolism","volume":"75","author":"Fanola","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rpth.2025.103208_bib49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.36628\/ijhf.2022.0006","article-title":"Left atrial remodeling and thromboembolic risk in patients with atrial fibrillation","volume":"4","author":"Chung","year":"2022","journal-title":"Int J Heart Fail"},{"key":"10.1016\/j.rpth.2025.103208_bib50","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13023-022-02320-x","article-title":"Current clinical practice for thromboprophylaxis management in patients with Cushing\u2019s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)","volume":"17","author":"Van Haalen","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rpth.2025.103208_bib51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4085\/1062-6050-47.5.08","article-title":"Natl Athletic Trainers\u2019 Assoc. National athletic trainers\u2019 association position statement: anabolic-androgenic steroids","volume":"47","author":"Kersey","year":"2012","journal-title":"J Athl Train"},{"key":"10.1016\/j.rpth.2025.103208_bib52","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1210\/jc.2018-01882","article-title":"Diagnosis and management of anabolic androgenic steroid use","volume":"104","author":"Anawalt","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rpth.2025.103208_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.sxmr.2017.04.001","article-title":"Erythrocytosis following testosterone therapy","volume":"6","author":"Ohlander","year":"2018","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.rpth.2025.103208_bib54","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rpth.2025.103208_bib55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41408-021-00463-x","article-title":"Phenotypical differences and thrombosis rates in secondary erythrocytosis versus polycythemia vera","volume":"11","author":"Nguyen","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.rpth.2025.103208_bib56","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1345\/aph.1H418","article-title":"Effect of oral corticosteroids on chronic warfarin therapy","volume":"40","author":"Hazlewood","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.rpth.2025.103208_bib58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","article-title":"Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids","volume":"44","author":"Czock","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.rpth.2025.103208_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-066846","article-title":"Drug\u2013drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case\u2013control study in the National COVID Cohort Collaborative (N3C)","volume":"12","author":"Kravchenko","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.rpth.2025.103208_bib60","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/cpt.3491","article-title":"The impact of dexamethasone and prednisone on apixaban and rivaroxaban exposure in COVID-19 patients: a physiologically based pharmacokinetic modeling study","volume":"117","author":"Terrier","year":"2025","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.rpth.2025.103208_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygcen.2010.07.004","article-title":"Cushing\u2019s syndrome, glucocorticoids and the kidney","volume":"169","author":"Smets","year":"2010","journal-title":"Gen Comp Endocrinol"},{"key":"10.1016\/j.rpth.2025.103208_bib62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40360-025-00871-w","article-title":"Risk factors for gastrointestinal complications during glucocorticoid therapy in internal medicine inpatients: a real-world retrospective analysis","volume":"26","author":"Liu","year":"2025","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.rpth.2025.103208_bib63","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1365-2125.2010.03752.x","article-title":"Corticosteroids therapy and peptic ulcer disease in nephrotic syndrome patients","volume":"70","author":"Hsiang","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rpth.2025.103208_bib64","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4330\/wjc.v15.i8.375","article-title":"Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: a cardiologic point of view","volume":"15","author":"Abrignani","year":"2023","journal-title":"World J Cardiol"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925005321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925005321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T02:43:14Z","timestamp":1767062594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037925005321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2475037925005321"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103208","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic complications of glucocorticoids and anabolic steroids","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103208"}}